Francesca Casaluce

A.O.R.N. San Giuseppe Moscati, AV
Avellino, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy.

Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy.

Journal: Frontiers in immunology

Published: September 05, 2023

Combined chemo-immunotherapy in advanced non-small cell lung cancer: feasible in the elderly?

Combined chemo-immunotherapy in advanced non-small cell lung cancer: feasible in the elderly?

Journal: Expert opinion on emerging drugs

Published: May 05, 2023

Critical points in the management of EGFR-mutated non-small cell lung cancer.

Critical points in the management of EGFR-mutated non-small cell lung cancer.

Journal: Journal of thoracic disease

Published: February 28, 2022

Narrative review of lung cancer treatment at the time of COVID-19 pandemia: pitfall and issues.

Narrative review of lung cancer treatment at the time of COVID-19 pandemia: pitfall and issues.

Journal: Translational lung cancer research

Published: February 11, 2021

The adjuvant regimen for resected EGFR mutated patients: the "same-for-all-therapy" or not?

The adjuvant regimen for resected EGFR mutated patients: the "same-for-all-therapy" or not?

Journal: Annals of translational medicine

Published: November 26, 2020

Immunotherapies in the management of epidermal growth factor receptor mutated non-small cell lung cancer: a role will be found?

Immunotherapies in the management of epidermal growth factor receptor mutated non-small cell lung cancer: a role will be found?

Journal: Translational lung cancer research

Published: February 02, 2019

The combination strategies will be ready the right first-line choice for squamous lung cancer patients?

The combination strategies will be ready the right first-line choice for squamous lung cancer patients?

Journal: Translational lung cancer research

Published: February 02, 2019

Frontline immunotherapy for NSCLC: alone or not alone?

Frontline immunotherapy for NSCLC: alone or not alone?

Journal: Nature reviews. Clinical oncology

Published: July 12, 2018

Lung cancer, elderly and immune checkpoint inhibitors.

Lung cancer, elderly and immune checkpoint inhibitors.

Journal: Journal of thoracic disease

Published: June 29, 2018

J-ALEX trial will crown alectinib as the standard choice for anaplastic lymphoma kinase positive untreated non-small cell lung cancer patients?

J-ALEX trial will crown alectinib as the standard choice for anaplastic lymphoma kinase positive untreated non-small cell lung cancer patients?

Journal: Journal of thoracic disease

Published: March 31, 2018

Targeted therapies in non-small cell lung cancer: a focus on ALK/ROS1 tyrosine kinase inhibitors.

Targeted therapies in non-small cell lung cancer: a focus on ALK/ROS1 tyrosine kinase inhibitors.

Journal: Expert review of anticancer therapy

Published: December 01, 2017

Second-Line Treatment Options in Non-Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology.

Second-Line Treatment Options in Non-Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology.

Journal: Clinical lung cancer

Published: August 02, 2017

Showing 1-12 of 42

Last Updated: 09/26/2026